title: DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.
authors: K H
authors: KH
authors: Metzeler
authors: A
authors: A
authors: Walker
authors: S
authors: S
authors: Geyer
authors: R
authors: R
authors: Garzon
authors: R B
authors: RB
authors: Klisovic
authors: C D
authors: CD
authors: Bloomfield
authors: W
authors: W
authors: Blum
authors: G
authors: G
authors: Marcucci
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics*; D000090205:DNA Methyltransferase 3A; D000077209:Decitabine; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation
chemical_list: D000964:Antimetabolites, Antineoplastic; C000717967:DNMT3A protein, human; D000077209:Decitabine; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; D001374:Azacitidine